Chris Eccles, CEO of ChargePoint Technology, reflected on the past two years and said: “The pandemic meant that the world changed in ways that no one could have imagined. At ChargePoint Technology, we supported our pharmaceutical customers in challenging times, ensuring they had the equipment they needed to maintain and scale the production of vital medicines and vaccines.
“We were on hand to help bring some of the first vaccines to market and worked around the clock to deliver vital manufacturing components in record time which enabled the manufacture of the vaccines. A customised version of our single-use transfer technology was designed and manufactured in just 3 days, despite the challenges of maintaining operations during the pandemic and associated supply chain issues.
“We’re so excited to showcase our operations and how we are continuing to thrive as a business.”
ChargePoint Technology’s multi-million-pound facility has highly skilled teams and machinery that create precision containment valves and single-use bags that are essential for the safe transfer of powders during pharmaceutical manufacturing.
ChargePoint Technology has grown its business by 20% in the last year and is continuing to expand with offices now in the US and Eastern Europe.
View our latest company news here.
